AVR — Anteris Technologies Global Corp. stock price, charts and financials
QT48Anteris Technologies Global Corp.Anteris Technologies Global Corp. (NASDAQ: AVR) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -3.25 | Insider Own | 19.45% | Shs Outstand | 97.23M | Perf Week | -2.28% |
| Market Cap | 795.26M | Forward P/E | - | EPS next Y | -1.13 | Insider Trans | -16.10% | Shs Float | 60.35M | Perf Month | -16.99% |
| Enterprise Value | 539.41M | PEG | - | EPS next Q | -0.31 | Inst Own | - | Short Float | 11.55% | Perf Quarter | -16.56% |
| Income | -84.00M | P/S | 198.35 | EPS this Y | 62.24% | Inst Trans | - | Short Ratio | 6.18 | Perf Half Y | 38.54% |
| Sales | 4.00M | P/B | 3.15 | EPS next Y | 7.72% | ROA | -38.01% | Short Interest | 6.97M | Perf YTD | 63.53% |
| Book/sh | 2.59 | P/C | 3.09 | EPS next 5Y | - | ROE | -77.66% | 52W High | 11.06 -26.22% | Perf Year | 45.45% |
| Cash/sh | 2.64 | P/FCF | - | EPS past 3/5Y | - | ROIC | -41.63% | 52W Low | 3.30 147.27% | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | Sales past 3/5Y | -12.64% -16.74% | Gross Margin | 36.98% | Volatility | 4.24% 4.21% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 134.85 | EPS Y/Y TTM | 13.79% | Oper. Margin | -4738.36% | ATR (14) | 0.40 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.20 | Sales Y/Y TTM | 33.33% | Profit Margin | -4619.67% | RSI (14) | 41.01 | Recom | 2.00 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.20 | EPS Q/Q | 48.28% | SMA20 | -5.42% | Beta | 1.45 | Target Price | 18.00 |
| Payout | 0.00% | Debt/Eq | 0.02 | Sales Q/Q | 0.00% | SMA50 | -5.80% | Rel Volume | 1.76 | Prev Close | 8.42 |
| Employees | 174 | LT Debt/Eq | 0.02 | Earnings | Nov 11 | SMA200 | 14.95% | Avg Volume | 1.03M | Price | 8.16 |
| IPO Date | Dec 13, 2024 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -44.72% -32.73% | Net Debt/EBITDA | 2.52 | Volume | 1,808,956 | Change | -3.09% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-15-26 | Reiterated | Barclays | Overweight | $18 |
| Jan-23-26 | Reiterated | Lake Street | $20 → $15 | |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight | $9.00 |
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4 | 2 | 3 | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 0 | 2 | 1 | — | — | — | — | |
| Gross Profit | 0 | 0 | 1 | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 0 | 24 | 0 | — | — | — | — | |
| Research and Development | 59 | 69 | 51 | — | — | — | — | |
| Other Operating Expense | 27 | 1 | 29 | — | — | — | — | |
| Operating Income | -86 | -94 | -78 | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 2 | 0 | 2 | — | — | — | — | |
| Net Income Before Taxes | -84 | -94 | -76 | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | — | — | — | — | |
| Consolidated Net Income | -84 | -94 | -76 | — | — | — | — | |
| Net Income From Continuing Operations | -84 | -94 | -76 | — | — | — | — | |
| Net Income | -84 | -94 | -76 | — | — | — | — | |
| EPS (Recurring) | -3.25 | -2.55 | -3.77 | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -3.25 | -2.55 | -3.77 | — | — | — | — | |
| EPS (Diluted) | -3.25 | -2.55 | -3.77 | — | — | — | — | |
| EBITDA | -84 | -92 | -74 | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 48.96 | 92.32 | 37.20 | — | — | — | — | |
| Gross Margin | 0.00 | 0.00 | 33.33 | — | — | — | — | |
| Operating Margin | -2,150.00 | -4,700.00 | -2,600.00 | — | — | — | — | |
| Net Margin | -2,100.00 | -4,700.00 | -2,533.33 | — | — | — | — | |
| Shares Outstanding | 24 | 37 | 20 | — | — | — | — | |
| Market Capitalization | 196 | 185 | 112 | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| L1 Capital Pty Ltd | 10% Owner | Aug 28 '26 | Sale | 8.83 | 7,800 | 68,874 | 4,803,541 | Sep 01 |
| St Denis David | Chief Operating Officer | Aug 19 '26 | Option Exercise | 5.65 | 60,000 | 339,000 | 161,082 | Aug 20 |
| L1 Capital Pty Ltd | 10% Owner | Aug 11 '26 | Sale | 9.30 | 375,815 | 3,495,080 | 4,811,341 | Aug 12 |
| L1 Capital Pty Ltd | 10% Owner | Aug 10 '26 | Sale | 9.10 | 251,844 | 2,291,780 | 5,187,156 | Aug 12 |
| L1 Capital Pty Ltd | 10% Owner | Aug 06 '26 | Sale | 8.10 | 174,721 | 1,415,240 | 5,439,000 | Aug 10 |
| L1 Capital Pty Ltd | 10% Owner | Aug 05 '26 | Sale | 8.23 | 14,581 | 120,002 | 5,613,721 | Aug 06 |
| L1 Capital Pty Ltd | 10% Owner | Aug 04 '26 | Sale | 8.30 | 480,608 | 3,989,046 | 5,628,302 | Aug 06 |
| L1 Capital Pty Ltd | 10% Owner | Aug 03 '26 | Sale | 8.10 | 475,693 | 3,853,113 | 6,108,910 | Aug 04 |
| L1 Capital Pty Ltd | 10% Owner | Jul 31 '26 | Sale | 8.15 | 48,711 | 396,995 | 6,584,603 | Aug 04 |
| L1 Capital Pty Ltd | 10% Owner | Jul 30 '26 | Sale | 8.20 | 558,633 | 4,580,791 | 6,633,314 | Jul 31 |
| L1 Capital Pty Ltd | 10% Owner | Jul 29 '26 | Sale | 8.04 | 155,505 | 1,250,260 | 7,191,947 | Jul 31 |
| L1 Capital Pty Ltd | 10% Owner | Jul 28 '26 | Sale | 8.09 | 208,731 | 1,688,634 | 7,347,452 | Jul 29 |
| L1 Capital Pty Ltd | 10% Owner | Jul 27 '26 | Sale | 6.78 | 281,161 | 1,906,771 | 5,359,470 | Jul 29 |
| L1 Capital Pty Ltd | 10% Owner | Jul 24 '26 | Sale | 8.13 | 23,000 | 186,990 | 7,789,000 | Jul 28 |
| L1 Capital Pty Ltd | 10% Owner | Jan 22 '26 | Buy | 5.75 | 10,000,000 | 57,500,000 | 13,219,814 | Jul 28 |